期刊文献+

缺血性卒中二级预防服用拜阿司匹林的依从性随访研究 被引量:22

Bayaspirin Compliance in Secondary Prevention of Ischemic Stroke:A Follow-up Study
下载PDF
导出
摘要 目的分析缺血性卒中患者出院后1年内使用拜阿司匹林的依从性及其影响因素,探讨解决办法。方法对我科连续出院的157例缺血性卒中患者进行随访,按其是否停药分为依从性好组和依从性差组,对其停用拜阿司匹林的原因及影响因素进行统计分析。结果157例患者中依从性差组39例(24.8%),依从性好组118例(75.2%),两组在文化水平、发病次数方面差异有统计学意义(P<0.05),在停药时间上66.67%的患者在1~2个月内停药,56.41%的患者是因为症状好转停药。结论患者中断服药的根本原因是因为对疾病的认识不够,开展广泛的科普教育是提高服药依从性的关键,对首次发病的患者在1~2月之间随访,进行跟踪指导可能是提高服药依从性的有效措施。 Objective To analyze the bayaspirin compliance in isehemic stroke (IS) patients within 1 year after dis- charge and its influencing factors, to find out its solution. Methods One hundred fifty - seven IS patients discharged from our department and followed up were divided into groups A ( with good compliance) and B ( with bad compliance ). The reasons and influencing factors of bayaspirin withdrawal were analyzed. Results There was significant difference in educational level and frequency of onset between groups A ( n = 118, 75.2% ) and B ( n = 39, 24. 8% ). In withdrawal time, 66. 67% patients stopped taking drugs within 1 - 2months, 56.41% did it because of improved symptoms. Conehmion The underlying reason for patients' drug withdrawal is lack of awareness of the disease. A wide range of science education is the key to improving patients' medication compliance. For patients with first attack, follow - up between 1 - 2 months may be an effective measure to improve medication compliance.
出处 《中国全科医学》 CAS CSCD 北大核心 2010年第2期153-154,共2页 Chinese General Practice
关键词 缺血性卒中 拜阿司匹林 抗血小板治疗 依从性 Ischemic stroke Bayaspirin Anti - platelet therapy Compliance
  • 相关文献

参考文献7

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 2Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healtheare professionals from the American Heart Association/American Stroke Association Council on Stroke : co - sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline[J]. Stroke, 2006, 37: 577-617.
  • 3Antithrombotie Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients [ J ]. BMJ, 2002, 324:71-86.
  • 4De Schryver EL, Van Gijn J, Kappelle LJ, et al. Dutch TIA trial and SPIRTT study groups. Non - adherence to aspirin or anticoagulants in seconddary prevention after ischaemic stroke [J]. J Neurol, 2005, 252: 1316-1321.
  • 5吴敌,马锐华,王伊龙,王拥军.缺血性卒中二级预防的药物依从性调查[J].中华内科杂志,2005,44(7):506-508. 被引量:38
  • 6Hillen T, Dundas R, Lawrence E, et al. Antithrombotic and antihypertensive management 3 months after ischemic stroke : aprospective study in an inner city population [J]. Stroke, 2000, 31:469-475.
  • 7张瑛,苗玲,林岩,沈沸,李红伟,陆钦池,李焰生.缺血性卒中患者抗栓药依从性研究[J].国际脑血管病杂志,2007,15(4):262-264. 被引量:6

二级参考文献18

  • 1吴敌,马锐华,王伊龙,王拥军.缺血性卒中二级预防的药物依从性调查[J].中华内科杂志,2005,44(7):506-508. 被引量:38
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 3Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.Antithrombotic Trialists′ Collaboration. BMJ,2002,324:71-86.
  • 4Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation Ⅲ randomised clinical trial.Lancet,1996,348:633-638.
  • 5Rudd AG, Lowe D, Hoffman A, et al. Secondary prevention for stroke in the United Kingdom: results from the National Sentinel Audit of Stroke.Age Ageing,2004,33:280-286.
  • 6Sappok T, Faulstich A, Stuckert E, et al.Compliance with secondary prevention of ischemic stroke: a prospective evaluation. Stroke, 2001,32:1884-1889.
  • 7Hamann GF, Weimar C, Glahn J, et al.Adherence to secondary stroke prevention strategies results from the German Stroke Data Bank.Cerebrovasc Dis, 2003,15:282-288.
  • 8Wolf PA, Clagett GP, Easton JD, et al.Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association.Stroke,1999,30:1991-1994.
  • 9Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet,2004,364:331-337.
  • 10Weber MA, Julius S, Kjeldsen SE, et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet, 2004,363:2049-2051.

共引文献33055

同被引文献152

引证文献22

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部